# Greening the curriculum: challenges in bringing environmental sustainability to pharmaceutical education

**Authors:** Cristina M. M. Almeida

PMC · DOI: 10.3389/fmed.2026.1770602 · Frontiers in Medicine · 2026-02-10

## TL;DR

This paper discusses the importance of integrating environmental sustainability into pharmaceutical education to address pollution and health risks from pharmaceutical practices.

## Contribution

The paper highlights the need to embed sustainability in pharmacy curricula to equip pharmacists with skills for green practices and safe drug management.

## Key findings

- Pharmaceutical activities contribute to environmental pollution and antimicrobial resistance.
- Training pharmacists in sustainability can improve medication management and reduce ecological harm.
- Real-world examples show pharmaceutical ingredients in water sources, emphasizing the urgency of this issue.

## Abstract

Environmental sustainability assumes a crucial dimension in modern pharmaceutical care, as the production, distribution, dispensing, and disposal of pharmaceutical products significantly contribute to environmental pollution and pose long-term health risks to the public. Pharmacists, as medication experts, play a central role in mitigating these risks through safe medication management, patient counseling, and advocacy for sustainable practices, working in close collaboration with prescribers and other healthcare professionals. It's essential to incorporate environmental sustainability into pharmaceutical curricula to prepare pharmacists for these challenges. Improper manufacturing and disposal of pharmaceuticals can contaminate soil and water, leading to antimicrobial resistance (AMR) and ecological disruption. Real-world examples, such as the detection of active pharmaceutical ingredients (APIs) in natural waters, biota, and drinking water, underscore the need to address these challenges. By embedding sustainability in education, future pharmacists develop competencies in green chemistry principles, medication review and optimization, formulary stewardship, and guidance on safe drug disposal, thereby strengthening the sustainability of the healthcare system. Several initiatives worldwide emphasize the practical necessity of this academic training. This dynamic relationship ensures that pharmacists act as both guardians of patient health and stewards of environmental wellbeing.

## Full-text entities

- **Diseases:** toxicity (MESH:D064420), asthma (MESH:D001249), cardiovascular disease (MESH:D002318), infections (MESH:D007239), chronic bronchitis (MESH:D029481), gastrointestinal infections (MESH:D005767), dependent cancers (MESH:D009369), endocrine disruption (MESH:D004700), AMR (MESH:D060467), carcinogenic (MESH:D011230), respiratory and cardiovascular diseases (MESH:D012140), endometrial cancer (MESH:D016889), deaths (MESH:D003643), respiratory problems (MESH:D012818), chronic (MESH:D002908), communicable diseases (MESH:D003141), intestinal diseases (MESH:D007410), COPD (MESH:D029424), diarrhea (MESH:D003967), ovarian cancer (MESH:D010051), breast cancer (MESH:D001943)
- **Chemicals:** ciprofloxacin (MESH:D002939), organochlorine (MESH:D006843), carbon (MESH:D002244), acetone (MESH:D000096), polymers (MESH:D011108), toluene (MESH:D014050), 17beta-estradiol (MESH:D004958), peroxides (MESH:D010545), trimethoprim (MESH:D014295), cephalosporins (MESH:D002511), dichloromethane (MESH:D008752), dichloro-diphenyl-trichloroethane (MESH:D003634), benzodiazepines (MESH:D001569), hydrofluoroalkane (MESH:C094049), penicillins (MESH:D010406), EE2 (-), ozone (MESH:D010126), clarithromycin (MESH:D017291), aluminum (MESH:D000535), azithromycin (MESH:D017963), methanol (MESH:D000432), RBs (MESH:D012413), sulfamethoxazole (MESH:D013420), ibuprofen (MESH:D007052), ethanol (MESH:D000431), VOCs (MESH:D055549), amoxicillin (MESH:D000658), erythromycin (MESH:D004917), sulfur dioxide (MESH:D013458), 17alpha-ethinylestradiol (MESH:D004997), guanylurea (MESH:C029280), carbapenems (MESH:D015780), chloroform (MESH:D002725), O-desmethylvenlafaxine (MESH:D000069468), nitrogen oxides (MESH:D009589), carbamazepine (MESH:D002220), CECs (MESH:C051731), clotrimazole (MESH:D003022), polypropylene (MESH:D011126), venlafaxine (MESH:D000069470), estrone (MESH:D004970), fluconazole (MESH:D015725), ofloxacin (MESH:D015242), Water (MESH:D014867), CO2 (MESH:D002245), GHG (MESH:D000074382), metformin (MESH:D008687), diclofenac (MESH:D004008), miconazole (MESH:D008825), clindamycin (MESH:D002981)
- **Species:** Homo sapiens (human, species) [taxon 9606], Escherichia coli (E. coli, species) [taxon 562], Danio rerio (leopard danio, species) [taxon 7955]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12929452/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12929452/full.md

## References

157 references — full list in the complete paper: https://tomesphere.com/paper/PMC12929452/full.md

---
Source: https://tomesphere.com/paper/PMC12929452